13F Pro Quality Score

72.3/100

Rank #232 of 2,879 stocksTOP 10%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

73.3/100

Profitability

85.6/100

Balance Sheet

78.4/100

Earnings Quality

92.5/100

Free Cash Flow

87.4/100

Institutional Flow

31.8/100

Revenue Scale

54.7/100

Dilution Risk

24.3/100

HQY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for HEALTHEQUITY, INC. (HQY), a Industrials sector company. 13F Pro's AI-powered ranking engine scores HQY at 72.3/100 on a 32-signal composite quality model, placing it at rank #232 of 2,879 stocks — the top 10% of the AI-ranked universe. HQY scores in the top quartile across earnings quality (92.5), free cash flow (87.4), profitability (85.6). Areas of concern include institutional flow (31.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2027), HEALTHEQUITY, INC. reports quarterly revenue of $354.6M, net income of $69.4M, an operating margin of 29.0%. Top institutional holders of HQY by reported 13-F value include BlackRock,, WASATCH ADVISORS, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. HQY trades on the Nasdaq exchange and files with the SEC under CIK 1428336. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HQY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HEALTHEQUITY, INC. directly from SEC EDGAR. HEALTHEQUITY, INC.'s 13F Pro composite quality score has ranged between 8 and 79 since 2021, currently 72.3 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about HEALTHEQUITY, INC.

Quirks, history, and lore behind HQY — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. financial technology company · mid-cap · listed on Nasdaq · headquartered in Utah.
  • 2
    The Numbers
    Serves over 15 million accounts and custodies more than $25 billion in assets — not bad for a company most people have never heard of.
  • 3
    The History
    Founded in the early 2000s, it was built to ride the wave of consumer-directed healthcare — a movement that really took off when high-deductible health plans went mainstream.
  • 4
    The Secret
    Its core product is essentially a tax-advantaged savings account tied to your health insurance — the kind that lets you pay for doctor bills with pre-tax dollars.
  • 5
    The Lore
    It partners with employers and health plans to administer benefits, making it a behind-the-scenes player every time someone swipes a benefits debit card at a pharmacy.
  • 6
    The Giveaway
    The dominant publicly traded custodian of Health Savings Accounts — if you have an HSA through your job, there's a real chance this Utah company is holding your money.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2027

$354.6M

Net Income

Q1 2027

$69.4M

Free Cash Flow

Q1 2027

$97.2M

Operating Margin

Q1 2027

29.0%

ROIC

Q1 2027

3.4%

D/E Ratio

Q1 2027

0.46

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+31.4% YoY
$1.31BFY 2026
FY22 $756.6MFY23 $861.7MFY24 $999.6MFY26 $1.31B

Net Income

+286.3% YoY
$215.2MFY 2026
FY22 $-44.3MFY23 $-26.1MFY24 $55.7MFY26 $215.2M

Operating Income

+174.0% YoY
$322.5MFY 2026
FY22 $-24.2MFY23 $9.1MFY24 $117.7MFY26 $322.5M

EPS (Diluted)

+284.4% YoY
$2.46FY 2026
FY22 $-0.53FY23 $-0.31FY24 $0.64FY26 $2.46

Total Assets

+6.8% YoY
$3.38BFY 2026
FY22 $3.11BFY23 $3.09BFY24 $3.16BFY26 $3.38B

Total Debt

+9.4% YoY
$957.4MFY 2026
FY22 $939.6MFY23 $942.8MFY24 $875.0MFY26 $957.4M

Op. Cash Flow

+88.2% YoY
$457.1MFY 2026
FY22 $141.0MFY23 $150.7MFY24 $242.8MFY26 $457.1M

Get alerted when HQY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HEALTHEQUITY, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of HQY

Put HQY on your watchlist

Track score changes the day HEALTHEQUITY, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HQY a good stock to buy?

13F Pro's AI-powered analysis of HEALTHEQUITY, INC. (HQY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HQY are available on the HQY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own HQY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HQY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HEALTHEQUITY, INC.'s investment landscape.